None of the tumours showed focal amplifications of AKT3, MDM2, KIT or MITF. Two patients showed CDK4 focal amplification and one patient had CCND1 focal amplification; however, these were preserved in all three patients during progression. This evidence concerns the gene MDM2 and neoplasm.